Abstract:Fragile X syndrome is caused by the lack of expression of fragile X mental retardation protein (FMRP), an RNA-binding protein involved in mRNA transport and translation. FMRP is a component of mRNA ribonucleoprotein complexes and it can interact with a range of proteins either directly or indirectly, as demonstrated by two-hybrid selection and co-immunoprecipitation, respectively. Most of FMRP-interacting proteins are RNA-binding proteins such as FXR1P, FXR2P and 82-FIP. Interestingly, FMRP can also interact directly with the cytoplasmic proteins CYFIP1 and CYFIP2, which do not bind RNA and link FMRP to the RhoGTPase pathway. The interaction with these different proteins may modulate the functions of FMRP by influencing its affinity to RNA and by affecting the FMRP ability of cytoskeleton remodeling through Rho/Rac GTPases. To better define the relationship of FMRP with its interacting proteins during brain development, we have analyzed the expression pattern of FMRP and its interacting proteins in the cortex, striatum, hippocampus and cerebellum at different ages in wild type (WT) mice. FMRP and FXR2P were strongly expressed during the first week and gradually decreased thereafter, more rapidly in the cerebellum than in the cortex. FXR1P was also expressed early and showed a reduction at later stages of development with a similar developmental pattern in these two regions. CYFIP1 was expressed at all ages and peaked in the third post-natal week. In contrast, CYFIP2 and 82-FIP (only in forebrain regions) were moderately expressed at P3 and gradually increased after P7. In general, the expression pattern of each protein was similar in the regions examined, except for 82-FIP, which exhibited a strong expression at P3 and low levels at later developmental stages in the cerebellum. Our data indicate that FMRP and its interacting proteins have distinct developmental patterns of expression and suggest that FMRP may be preferentially associated to certain proteins in early and late developmental periods. In particular, the RNA-binding and cytoskeleton remodeling functions of FMRP may be differently modulated during development.

Fragile X Mental Retardation Protein Modulates the Stability of Its M6a-Marked Messenger RNA Targets.

The RNA-binding protein FMRP facilitates the nuclear export of N6-methyladenosine–containing mRNAs

FMRP Modulates Neural Differentiation through m6A-Dependent mRNA Nuclear Export

FMRP Acts As a Key Messenger for Dopamine Modulation in the Forebrain

The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain

A noncanonical RNA-binding domain of the fragile X protein, FMRP, elicits translational repression independent of mRNA G-quadruplexes

Fragile X mental retardation protein (FMRP) interacting proteins exhibit different expression patterns during development

FMRP links optimal codons to mRNA stability in neurons

Characterization of ribosome stalling and no-go mRNA decay stimulated by the Fragile X protein, FMRP

FMRP inhibits translation elongation independent of mRNA G-quadruplexes

FMRP phosphorylation modulates neuronal translation through YTHDF1

Altering rRNA 2'O-methylation pattern during neuronal differentiation is regulated by FMRP

The G-Quartet Containing Fmrp Binding Site in Fmr1 Mrna is A Potent Exonic Splicing Enhancer

Fragile X Mental Retardation Protein Regulates Proliferation and Differentiation of Adult Neural Stem/Progenitor Cells

Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation Via Distinct Mechanisms

Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay

Fragile X Messenger Ribonucleoprotein Protein and Its Multifunctionality: From Cytosol to Nucleolus and Back

Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse

The Fragile X Mental Retardation Protein Fmrp Plays A Role In The Dna Damage Response

FMRP regulates miR196a-mediated repression of HOXB8 via interaction with the AGO2 MID domain.

The molecular biology of FMRP: new insights into fragile X syndrome